PRIMECAP Management's position in GSK Plc is currently worth $987 Million. That's 0.73% of their equity portfolio (39th largest holding). The investor owns 1.25% of the outstanding GSK Plc stock. The first GSK Plc trade was made in Q1 2013. Since then PRIMECAP Management bought shares eleven more times and sold shares on 24 occasions. The investor's estimated purchase price is $992 Million, resulting in a loss of 0.5%.
Billionaire Ken Griffin Goes Heavy On This Tech Stock, Increases Stake By 200% In Two Quarters (IBTimes) Big Asset Managers Including Morgan Stanley, Citadel...
… the SEC. The institutional investor owned 15,255 shares … reporting period. Other institutional investors have also recently made … quarter. Indiana Trust ...
Brett Swansiger joins as Chief Commercial Officer Karen Miller PhD joins as Chief Scientific Officer GUILDFORD, SURREY / ACCESSWIRE / June 5, 2023 / ANGLE pl...
Start Time: 09:45 End Time: 10:18 GSK plc (NYSE:NYSE:GSK) dbAcess Global Consumer Conference June 14, 2022, 09:45 AM ET Company Participants Tobias Hestler -...